| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10964200 | Vaccine | 2015 | 6 Pages |
Abstract
After implementation of the universal single-dose vaccination against HA in infants in Argentina, an impressive decline was observed in HA cases, with a decrease in medical and non-medical costs in the first 5 years. The single-dose strategy, which is simpler and less expensive than the standard two-dose scheme, can be a good alternative for future vaccination policies in other countries where HA is endemic.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
C. Vizzotti, T. Pippo, A. Urueña, J. Altuna, G. Palópoli, M.L. Hernández, M.F. Artola, H. Fernández, P. Orellano, M.C. Cañero-Velasco, M. Ciocca, M. Ramonet, M. Diosque,
